- socially bharat
- October 3, 2024
Saniona’s CEO to BioStock: “SAN2355 is a highly promising candidate for commercialization”
Thu, Oct 03, 2024 09:45 CET Report this content Saniona has announced significant progress in the preclinical development
READ MORE